News
Heart failure (HF) remains a significant cardiovascular public health concern in India, affecting an estimated 1.3 to 22.7 ...
TipRanks on MSN16h
Novo Nordisk’s Promising Heart Failure Study: A Market Game-Changer?
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk is conducting a Phase 2 study titled ‘A Research Study ...
TipRanks on MSN16h
Novo Nordisk’s Ziltivekimab Study: A Potential Game-Changer for Heart Failure Treatment
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled ‘Effects ...
Patients with severely disturbed sleep had the highest comorbidity burden, lowest ejection fraction, and poorest cognitive ...
Two new medications—tirzepatide and setmelanotide—are now recommended, and the guideline includes updated advice for treating obesity in people with certain complications, including atherosclerotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback